MedTrace Logo

Dairy Lipids and Cardiometabolic Risk

NCT05783466 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2025-06-18

No results posted yet for this study

Summary

It is a randomized parallel arm intervention study in adults with severe obesity. The objective is to demonstrate that within a dietary handling for weight loss, the daily ingestion during 3 months of whole dairy products enriched with milk polar lipids or whole dairy products decreases to a greater extent fasting plasma apolipoprotein B concentrations than the daily ingestion of low-fat dairy products (control group).

Metabolic parameters will be assessed before and after the 3-month intervention, both at fasting and in postprandial period after the consumption of standardized meals.

Conditions

  • Morbid Obesity

Interventions

OTHER

Low-fat dairy products

3-month intervention

OTHER

Whole-fat dairy products

3-month intervention

OTHER

Milk polar lipid enriched whole-fat dairy products

3-month intervention

Sponsors & Collaborators

  • Laboratoire de Recherche en Cardiovasculaire, Métabolisme, Diabétologie et Nutrition

    collaborator UNKNOWN

  • Centre de Recherche en Nutrition Humaine Rhone-Alpe

    collaborator OTHER

  • Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

    collaborator OTHER

  • Hospices Civils de Lyon

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-28
Primary Completion
2026-10-31
Completion
2026-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05783466 on ClinicalTrials.gov